BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 171277)

  • 21. MORE THAN MEETS THE EYE IN A PATIENT WITH PCOS: ANDROGEN-SECRETING GRANULOSA CELL OVARIAN TUMOR IN A VIRILIZED WOMAN WITH POLYCYSTIC OVARIAN SYNDROME (PCOS).
    Harris AA; Kabadi UM
    AACE Clin Case Rep; 2020; 6(4):e170-e173. PubMed ID: 32734001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen and estrogen formation in women with ovarian hyperthecosis.
    Aiman J; Edman CD; Worley RJ; Vellios F; MacDonald PC
    Obstet Gynecol; 1978 Jan; 51(1):1-9. PubMed ID: 619322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined ovarian vein catheterization with ovarian stimulation in the diagnosis of androgen overproduction.
    Cohen I; Cuperman S; Altaras MM; Ben-Nun I; Goldberg E; Beyth Y
    Acta Obstet Gynecol Scand; 1992 Apr; 71(3):245-8. PubMed ID: 1317653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
    Piltonen T; Koivunen R; Perheentupa A; Morin-Papunen L; Ruokonen A; Tapanainen JS
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3769-75. PubMed ID: 15292303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
    Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
    Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
    Veldhuis JD; Pincus SM; Garcia-Rudaz MC; Ropelato MG; Escobar ME; Barontini M
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome.
    Apter D; Bützow T; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1994 Jul; 79(1):119-25. PubMed ID: 8027216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).
    Conte FA; Grumbach MM; Ito Y; Fisher CR; Simpson ER
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1287-92. PubMed ID: 8200927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steroid cell tumor of the ovary as a rare cause of virilization.
    Azizlerli H; Tanakol R; Terzioğlu T; Alagöl F; Dizdaroglu F
    Mt Sinai J Med; 1997 Mar; 64(2):130-5. PubMed ID: 9057471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral and Ovarian Steroids in Ovarian Hyperthecosis.
    Abraham GE; Buster JE
    Obstet Gynecol; 1976 May; 47(5):581-6. PubMed ID: 1264403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial "sarcomas" complicating ovarian thecoma, polycystic ovarian disease and estrogen therapy.
    Press MF; Scully RE
    Gynecol Oncol; 1985 Jun; 21(2):135-54. PubMed ID: 2985476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary aldosteronism due to a malignant ovarian tumor.
    Todesco S; Terribile V; Borsatti A; Mantero F
    J Clin Endocrinol Metab; 1975 Nov; 41(5):809-19. PubMed ID: 171276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycystic ovarian disease: clinical considerations.
    Goldfarb AF
    J Reprod Med; 1977 Mar; 18(3):135-8. PubMed ID: 857017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testosterone secretion by cultured arrhenoblastoma cells: suppression by a luteinizing hormone-releasing hormone agonist.
    Lamberts SW; Timmers JM; Oosterom R; Verleun T; de Jong FH
    J Clin Endocrinol Metab; 1982 Feb; 54(2):450-4. PubMed ID: 6274906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilateral ovarian thecosis and virilization in pregnancy. A case report.
    Rivera-Alsina ME; DeSanctis VM; Schmidt WA
    J Reprod Med; 1987 Nov; 32(11):873-8. PubMed ID: 2828613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hilus cell tumor of the ovary. A clinicopathological analysis of 12 Reinke crystal-positive and nine crystal-negative cases.
    Paraskevas M; Scully RE
    Int J Gynecol Pathol; 1989; 8(4):299-310. PubMed ID: 2553628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrone and estradiol concentrations in human ovaries, testes, and adrenals during the first two years of life.
    Bidlingmaier F; Strom TM; Dörr HG; Eisenmenger W; Knorr D
    J Clin Endocrinol Metab; 1987 Nov; 65(5):862-7. PubMed ID: 3667883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroid section patterns of a hilus cell tumor of the ovary.
    Nagamani M; Gonzalez-Vitale JC
    Obstet Gynecol; 1981 Oct; 58(4):521-7. PubMed ID: 7279348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgenic response in anovulatory women during menotropins stimulation.
    Skaf RA; Shelden R; Kemmann E
    Obstet Gynecol; 1981 Dec; 58(6):714-9. PubMed ID: 6796920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.